Newer Treatment Strategies for Treatment of Hepatic Encephalopathy in ACLF
752 Views
Dr RK Dhiman 05 December 2018
HE with all grades of severity and independent of other organ failures is associated with increased mortality; the mortality is higher in grade 3-4 compared with grade 1-2 HE.
Inflammation plays a greater role in the pathogenesis of HE in patients with ACLF than in patients without ACLF and is associated with cytokine storm.
Ammonia is a simple surrogate marker for HE in ACLF and correlates with severity of HE/cerebral failure.
Ammonia levels at baseline > 144 mmol/l predicts mortality.
Management of HE in hospitalized patients requires admission to the ICU and includes identification and treatment of precipitating factors, including infections; and specific measures for decreasing hyperammonemia and systemic inflammation.
Large volume plasmapheresis or albumin dialysis and identification and embolization of portosystemic shunts may be required in refractory patients.
To comment on this article, create a free account.
Sign Up to instantly get access to 10000+ Articles & 1000+ Cases
eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.